Mar 07, 2017 – Mar 09, 2017
Advancements towards safer adoptive cell therapies: Immatics to present at the WORLD ADOPT Summit, London

Advancements towards safer adoptive cell therapies: Immatics to present at the WORLD ADOPT Summit (March 7-9, London)

Date/ Time: Wednesday, March 8, 2017/ 12pm - 12.30pm

Yannick Bulliard, Director Product Science, Immatics US Inc.

Session: Innovating Cell Therapy Targeting

Title: XPRESIDENT®-Guided Target Identification and Profiling of On- and Off-Target Toxicity for Safer Adoptive Cell Therapy

We are looking forward to a fruitful exchange of ideas and experiences at this year's event!

For further information please contact us!

For more information on the WORLD ADOPT Summit: click

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back